The Supreme Court unanimously preserved access to medication used in two-thirds of U.S. abortions, rejecting abortion opponents' legal challenge over FDA approval and access to mifepristone.
Mifepristone has been crucial for over 6 million individuals since 2000 in ending pregnancies through 10 weeks gestation, playing a vital role in reproductive healthcare access.
[
add
]
[
|
|
...
]